Wednesday, January 26, 2022
Home Covid-19 Pfizer files for U.S. authorization of its pill to treat COVID-19

Pfizer files for U.S. authorization of its pill to treat COVID-19

Pfizer Inc said on Tuesday it is seeking U.S. authorization of its experimental antiviral COVID-19 pill that cut the chance of hospitalization or death for adults at risk of severe disease by 89% in a clinical trial.

Pfizer said it completed submission of its application for emergency use authorization (EUA) of the drug, Paxlovid, with the U.S. Food and Drug Administration, including data from the drugmaker’s clinical trial.

The oral drug could be promising new weapon in the fight against the pandemic, as it can be taken as an early at-home treatment to help prevent COVID-19 hopitalizations and deaths. It could also become a important tool in countries and areas with limited access to vaccines or low vaccination rates.

Read more:
New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says

Story continues below advertisement

It is not immediately clear when U.S. regulators will rule on Pfizer’s application. Merck & Co Inc and Ridgeback Biotherapeutics, which are developing a competing pill, molnupiravir, completed their EUA submission on Oct. 11.

A panel of outside advisers to the FDA will meet to consider that application on Nov. 30, and it is expected to be available this year.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer Chief Executive Albert Bourla said in a news release.

The New York-based drugmaker said it has begun the process of seeking authorization in several countries including the United Kingdom, Australia, New Zealand and South Korea, and plans further international submissions.

Read more:
Pfizer to allow other companies to make its COVID-19 pill

Pfizer said earlier on Tuesday it will allow generic manufacturers to supply its COVID-19 pill to 95 low- and middle-income countries through a licensing agreement with international public health group Medicines Patent Pool (MPP).

© 2021 Reuters

Most Popular

North Korea fires 2 suspected cruise missiles into sea, Seoul military officials say

North Korea on Tuesday test-fired two suspected cruise missiles in its fifth round of weapons launches this month, South Korean military officials said, as...

5 more COVID-19 deaths reported in Waterloo Region Monday

After reporting six COVID-19-related deaths on Friday, Waterloo Public Health reported another five on Monday, raising the death toll in the area to 339. A...

COVID-19: Six Hamilton schools reporting absence rates of 30% or higher

Hamilton’s top doc says the city’s school boards and public health are still “working through” what a 30 per cent or higher in-person absentee...

‘This is destroying us’: Popular Toronto restaurant closes outdoor patio following violations

A popular outdoor patio at a Toronto restaurant in Little Italy is closed for business after the owner of Café Diplomatico said he received...